Sentinel Lymph Node Biopsy for Locally Recurrent Oral Squamous Cell Carcinoma with a Previously Treated Neck
- PMID: 40690172
- DOI: 10.1245/s10434-025-17907-4
Sentinel Lymph Node Biopsy for Locally Recurrent Oral Squamous Cell Carcinoma with a Previously Treated Neck
Abstract
Background: Neck management in recurrent cN0 oral squamous cell carcinoma (SCC) remains controversial. We aimed to elucidate the utilization of sentinel lymph node (SLN) biopsy in recurrent oral SCC.
Methods: Patients with locally recurrent cN0 oral SCC who underwent SLN biopsy were retrospectively analyzed. The primary outcome variable was the diagnostic accuracy of SLN biopsy, alongside an examination of aberrant drainage in relation to previous neck interventions, wherein aberrant drainage was defined as SLNs situated outside ipsilateral levels I-III or in the contralateral neck.
Results: A total of 169 patients were included, achieving an SLN detection rate of 100%. SLN biopsy confirmed nodal metastasis in 29 patients, but failed to identify 9 cases, leading to a false negative rate (FNR) of 23.7% and a negative predictive value (NPV) of 93.6%. The efficacy of the biopsy was influenced by prior neck management, with the elective neck dissection (END) + radiotherapy cohort exhibiting the highest FNR of 26.1% and the lowest NPV of 90.0%. Aberrant lymphatic drainage was documented in 54 patients, with 30 cases demonstrating ipsilateral drainage and 14 cases revealing contralateral drainage. The END group recorded the highest number of SLNs detected, while the END + radiotherapy group displayed the greatest propensity for aberrant lymphatic drainage and non-SLN metastasis.
Conclusions: In patients with locally recurrent oral SCC, SLN biopsy showcased a commendable capacity to show aberrant lymphatic drainage and detect occult metastases, although false negative results were prevalent among individuals previously treated with END and radiotherapy.
Keywords: Elective neck dissection; Lymphatic drainage; Oral squamous cell carcinoma; Radiotherapy; Sentinel lymph node biopsy.
© 2025. Society of Surgical Oncology.
Conflict of interest statement
Disclosure: Qigen Fang, Junhui Yuan, and Tao Huang have declare no conflict of interest that may be relevant to the contents of this study. Ethics Approval and Consent to Participate: This study was approved by our Institutional Research Committee, and written informed consent for medical research was obtained from all patients prior to initial treatment. All methods were performed in accordance with relevant guidelines and regulations. Consent for Publication: Not applicable.
Similar articles
-
Robot assisted sentinel lymph node biopsy using indocyanine green combined with carbon nanoparticles staining improved detection rates in breast cancer.Sci Rep. 2025 Jul 1;15(1):21366. doi: 10.1038/s41598-025-06338-6. Sci Rep. 2025. PMID: 40594378 Free PMC article.
-
Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature.Dermatol Surg. 2006 Nov;32(11):1309-21. doi: 10.1111/j.1524-4725.2006.32300.x. Dermatol Surg. 2006. PMID: 17083582
-
A prospective study of sentinel lymph node detection in vulval carcinoma: is it time for a change in clinical practice?Int J Gynecol Cancer. 2011 Apr;21(3):559-64. doi: 10.1097/IGC.0b013e3182119d8d. Int J Gynecol Cancer. 2011. PMID: 21430459 Clinical Trial.
-
Sentinel lymph node biopsy versus elective neck dissection in management of the clinically negative (cN0) neck in patients with oral squamous cell carcinoma: A systematic review and meta-analysis.J Craniomaxillofac Surg. 2024 Feb;52(2):141-150. doi: 10.1016/j.jcms.2023.12.012. Epub 2024 Jan 3. J Craniomaxillofac Surg. 2024. PMID: 38195297
-
Lymphatic mapping Of Oropharyngeal Cancer (LOOC): protocol for a phase II surgical imaging trial to evaluate contralateral drainage and occult metastasis in oropharyngeal cancer.BMJ Open. 2025 Jun 5;15(6):e101746. doi: 10.1136/bmjopen-2025-101746. BMJ Open. 2025. PMID: 40473291 Free PMC article.
References
-
- Rich BJ, Samuels SE, Azzam GA, Kubicek G, Freedman L. Oral cavity squamous cell carcinoma: review of pathology, diagnosis, and management. Crit Rev Oncog. 2024;29:5–24. - PubMed
-
- Lorini L, Gili R, Salvestrini V, Morelli I, Smussi D, Petrelli F, et al. De novo metastatic head and neck squamous cell carcinoma: why does locoregional control “always” matter? Oral Oncol. 2024;152:106768. - PubMed
-
- Garg M, Tudor-Green B, Bisase B. Current thinking in management of the neck (including contralateral neck) in ipsilateral recurrent or second primary oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2019;57:711–5. - PubMed
-
- Garrel R, Poissonnet G, Moyà Plana A, Fakhry N, Dolivet G, Lallemant B, et al. Equivalence randomized trial to compare treatment on the basis of sentinel node biopsy versus neck node dissection in operable T1–T2N0 oral and oropharyngeal cancer. J Clin Oncol. 2020;38:4010–8. - PubMed
-
- Hasegawa Y, Tsukahara K, Yoshimoto S, Miura K, Yokoyama J, Hirano S, et al. Neck dissections based on sentinel lymph node navigation versus elective neck dissections in early oral cancers: a randomized, multicenter, and noninferiority trial. J Clin Oncol. 2021;39:2025–36. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials